Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page footer’s software/build revision number was updated from v3.5.2 to v3.5.3, reflecting a maintenance/update of the ClinicalTrials.gov site rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:17:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:54.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    The history shows an addition of Revision: v3.5.0 and a deletion of Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T02:55:10.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.3, was added to the record history and the previous revision, v3.4.2, was removed. This is an administrative update to the page's version history.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:21.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.4.2 and removal of v3.4.1. This is a metadata update to the page with no changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:52.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.1 and removes v3.4.0, reflecting a system site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:00:22.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.